Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-25-000077
Filing Date
2025-08-08
Accepted
2025-08-08 16:21:30
Documents
76
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20250630.htm   iXBRL 10-Q 915585
2 EX-31.1 exicureexhibit311-63025.htm EX-31.1 7646
3 EX-31.2 exicureexhibit312-63025.htm EX-31.2 7661
4 EX-32.1 exicureexhibit321-63025.htm EX-32.1 8116
  Complete submission text file 0001698530-25-000077.txt   5556665

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250630.xsd EX-101.SCH 48780
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20250630_cal.xml EX-101.CAL 73197
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20250630_def.xml EX-101.DEF 181900
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250630_lab.xml EX-101.LAB 561002
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250630_pre.xml EX-101.PRE 391872
79 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250630_htm.xml XML 601757
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 251198737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)